Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.54
-0.02 (-1.28%)
At close: Sep 25, 2025, 3:59 PM
1.54
0.00%
After-hours: Sep 25, 2025, 05:10 PM EDT
-1.28% (1D)
| Bid | 1.51 |
| Market Cap | 48.44M |
| Revenue (ttm) | 848K |
| Net Income (ttm) | -85.96M |
| EPS (ttm) | -2.24 |
| PE Ratio (ttm) | -0.69 |
| Forward PE | -0.73 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.64 |
| Volume | 326,715 |
| Avg. Volume (20D) | 1,324,785 |
| Open | 1.56 |
| Previous Close | 1.56 |
| Day's Range | 1.51 - 1.62 |
| 52-Week Range | 1.05 - 8.74 |
| Beta | 1.67 |
| Ex-Dividend Date | n/a |
About ACRV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-17.59%
ACRV stock has given up its prior gain. Acrivion T...
Unlock content with
Pro Subscription
5 months ago
-17.59%
Acrivion Therapeutics shares are trading higher after the company announced it will present data from its analysis of ACR-2316.
